Specialization drives our success
Our founding partners leverage their personal and professional life experiences at the intersection of capital and big ideas. Our unanimous decision culture works due to the diverse, yet complementary composition of the team.
We are driven by the Double-Result successes of our investments. Our stewardship commitment to each other and our investors revolves around our shared belief to selflessly serve our investors, associates & vendors.
Chief Investment Officer
Dr. Quentin J. Florence
Chief Investment Officer
Dr. Florence has over 20 years of experience in the biotechnology industry with roles in scientific and business development.
Quentin has a background in both vital scientific research and IP and commercialization; quickly assessing the investment viability of every portfolio opportunity. He is a gifted networker comfortably connecting with targets and investors. He served as the lead scientist and business development coordinator for rPeptide, a company that was focused on the evolution, quality testing, and manufacturing of Alzheimer’s related research products.
He has overseen market research, product manufacturing, technology transfer, customer relations, research and development as well as other administrative and scientific activities for several companies.
Most recently, Dr. Florence has served on the advisory boards for several companies including AEP BioFuels LLC, Razar Technologies and Share Capital LLC . He captures the transformative impact or “WOW” factor of our investments.
PRESIDENT
Doug Vander Linde
President
With over 40 years of global investment leadership in alternatives, asset management, OCIO, bundled services, and options, Doug was recently CEO of a $5B emerging minority equity manager. Prior global leadership roles were with prominent investment consultants Willis Towers Watson & Mercer; connecting with the largest and most sophisticated global pools of institutional capital.
Doug provides impartial, market-centric, outcomes-focused, perspectives on our future strategic investment opportunities. Drawing on significant investment credentials, in product and market transformation with bank Northern Trust, mutual fund provider Putnam Investments and insurance asset solutions specialist Met Life and State Street Research.
Doug served as an Irish QIAIF fund trustee for the $35B TWIM Fund Series as well as several for-profit and charitable boards. Recently, Doug was President, CEO and Chief Compliance Officer for Herndon Capital Management. He is regarded as the “WAY-maker” of the team in executing our mission, reach, impact, vision and values.
Expertise at the intersection of capital and big ideas
digital health
Self-care for healthier lifestyles
Therapeutics
Favorable medicinal outcomes
Medical devices
Better testing. better results
FOOD
Safe, sustainable,
and scalable
Water
Clean and
accessible
Energy
Secure, renewable
and efficient
Let’s build a lasting legacy, together
What we are doing for our investors really matters long term. Our joy as a more-than-for-profit firm is seeing our fund blessings used to bless others.